Replies to post #3377 on Lexington Biosciences Inc. (LXGTF)

[StockBro75]

LXGTF in the last PR said that they had received the first HeartSentry monitors from the manufacturer and were commencing clinical trials "as soon as possible". They are in the FDA preapproval 510K clearance track, and the average time to market for cardiovascular devices in that track is 4 to 5 months. The PR came out Oct 23rd so investors could conceivably be getting some great news about FDA clearance 1st quarter of 2018. That being said, there are few milestones within the clinical testing process itself that the company might disclose along the way as well.
https://lexingtonbiosciences.com/news/lexington-biosciences-receives-heartsentry-trial-units/